| Purpose | Board Meetings Date | Announcement Date |
|---|---|---|
| Board Meeting | 5 Sep 2026 | 27 Aug 2026 |
| KMS Medisurgi Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/09/2026 inter alia to consider and approve Intimation of Board Meeting scheduled to be held on Saturday 5th September 2026 Outcome of Board meeting held on Saturday, 05th September, 2026 (As per BSE Announcement dated on: 05.09.2026) | ||
| Board Meeting | 30 May 2026 | 25 May 2026 |
| Audited Results. Submission of Standalone Audited financial result for the year ended 31.03.2026. (As per BSE announcement dated on : 30.05.2026) | ||
| Board Meeting | 14 Nov 2025 | 6 Nov 2025 |
| KMS Medisurgi Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2025 inter alia to consider and approve This is to inform you that Pursuant to Regulation 29 and 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we wish to inform you that the meeting of the Board of Directors of the Company is scheduled to be held on Friday November 14 2025 at 1:00 pm at the registered office of the Company to consider and approve: 1. The Un-Audited Financial Results of the Company for the half year ended 30th September 2025 and the Limited review report thereon; 2. Any other items if any Further in terms of Companys Code of Conduct for Prevention of insider Trading the closure of trading window for purchase/sale of securities of the Company by the Designated persons and their immediate relatives has already commenced from October 1 2025 and will end Forty-Eight (48) hours after the declaration of Financial Results of the Company for the Half year ended on 30th September 2025. Board of Directors of the company at its meeting held by today have inter alia considered, approved and taken on record the unaudited standalone financial statement of the company for the half year ended 30th September, 2025 Submission of Unaudited financial results for the Half year ended September 30, 2025 (As Per BSE Announcement Dated on 14.11.2025) | ||
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
